NEW YORK, June 30, 2014 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), an ophthalmology research and development company, today announced that the Company was added to the Russell Global, Russell 3000, and the Russell Microcap Indexes when Russell Investments reconstituted its comprehensive set of U.S. and global equity indices on June 27, 2014.
Help employers find you! Check out all the jobs and post your resume.
